Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity

Journal of Drug Targeting

Volumn 21, Issue 5, 2013, Pages 466-473

  Alipour, Misagh ^a,b   Buonocore, Caroline ^a   Omri, Abdelwahab ^b   Szabo, Mary ^a   Pucaj, Kresimir ^c   Suntres, Zacharias E ^a,b  

^a LAKEHEAD UNIVERSITY   (Canada)

^b LAURENTIAN UNIVERSITY   (Canada)

^c Nucro Technics   (Canada)

Author keywords

Acetaminophen; Inflammation; Liposomes; Liver; N acetylcysteine; Oxidative stress; Peroxidation

Indexed keywords

ACETYLCYSTEINE DERIVATIVE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPOSOMAL N ACETYLCYSTEINE; MYELOPEROXIDASE; PARACETAMOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; DRUG BLOOD LEVEL; DRUG HALF LIFE; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER TOXICITY; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THERAPY EFFECT;

ACETAMINOPHEN; ACETYLCYSTEINE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; BODY WEIGHT; CHEMISTRY, PHARMACEUTICAL; DRUG-INDUCED LIVER INJURY; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDATION; LIPOSOMES; LIVER; MALE; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84878620325     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2013.765443     Document Type: Article

References (69)

1. Chun LJ, Tong MJ, Busuttil RW, Hiatt Jr. Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol 2009;43:342-9.
2. Hinson JA, Roberts DW, James LP. Mechanisms of acetaminopheninduced liver necrosis. Handb Exp Pharmacol 2010;196:369-405.
3. Lee WM. Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 2004;40:6-9.
4. Mitchell JR, Jollow DJ, Potter WZ, et al. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther 1973;187:185-94.
5. Zhao L, Pickering G. Paracetamol metabolism and related genetic differences. Drug Metab Rev 2010;43:41-52.
6. Jaeschke H, Gores GJ, Cederbaum AI, et al. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-76.
7. Srivastava A, Maggs JL, Antoine DJ, et al. Role of reactive metabolites in drug-induced hepatotoxicity. Handb Exp Pharmacol 2010;196:165-94.
8. Brand MD, Affourtit C, Esteves TC, et al. Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins. Free Radic Biol Med 2004;37:755-67.
9. Casteilla L, Rigoulet M, Penicaud L. Mitochondrial ROS metabolism: modulation by uncoupling proteins. IUBMB Life 2001; 52:181-8.
10. Jaeschke H, Knight TR, Bajt ML. The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity. Toxicol Lett 2003;144:279-88.
11. Koop DR. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J 1992;6:724-30.
12. Buckley NA, Eddleston M, Li Y. IV versus oral acetylcysteine. Ann Emerg Med 2010;55:393-4.
13. Gupta AK, Su MK, Greller HA, et al. IV versus oral N-acetylcysteine. Ann Emerg Med 2009;54:857-8.
14. Klein-Schwartz W, Doyon S. Intravenous acetylcysteine for the treatment of acetaminophen overdose. Expert Opin Pharmacother 2011;12:119-30.
15. Lopez DP. Emergency: acetaminophen poisoning. Am J Nurs 2009;109:48-51.
16. Yang R, Miki K, He X, et al. Prolonged treatment with N-acetylcystine delays liver recovery from acetaminophen hepatotoxicity. Crit Care 2009;13:R55-61.
17. Tan HH, Chang CY, Martin P. Acetaminophen hepatotoxicity: current management. Mt Sinai J Med 2009;76:75-83.
18. Marzullo L. An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr 2005; 17:239-45.
19. Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009;47:81-8.
20. Yarema MC, Johnson DW, Berlin RJ, et al. Comparison of the 20- hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med 2009;54:606-14.
21. Alipour M, Omri A, Smith MG, Suntres ZE. Prophylactic effect of liposomal N-acetylcysteine against LPS-induced liver injuries. J Endotoxin Res 2007;13:297-304.
22. McClintock SD, Hoesel LM, Das SK, et al. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J Appl Toxicol 2006;26:126-31.
23. Mitsopoulos P, Omri A, Alipour M, et al. Effectiveness of liposomal-N-acetylcysteine against LPS-induced lung injuries in rodents. Int J Pharm 2008;363:106-11.
24. Drulis-Kawa Z, Dorotkiewicz-Jach A. Liposomes as delivery systems for antibiotics. Int J Pharm 2010;387:187-98.
25. Stone WL, Smith M. Therapeutic uses of antioxidant liposomes. Mol Biotechnol 2004;27:217-30.
26. Suntres ZE. Role of antioxidants in paraquat toxicity. Toxicology 2002;180:65-77.
27. Suntres ZE. Liposomal antioxidants for protection against oxidantinduced damage. J Toxicol 2011;2011:152474-89.
28. Suntres ZE, Shek PN. Prophylaxis against lipopolysaccharideinduced acute lung injury by alpha-tocopherol liposomes. Crit Care Med 1998;26:723-9.
29. Suntres ZE, Shek PN. Prophylaxis against lipopolysaccharideinduced lung injuries by liposome-entrapped dexamethasone in rats. Biochem Pharmacol 2000;59:1155-61.
30. Buonocore C, Alipour M, Omri A, et al. Treatment of ricin A-chain-induced hepatotoxicity with liposome-encapsulated N-acetylcysteine. J Drug Target 2011;19:821-9.
31. Alipour M, Smith MG, Pucaj K, Suntres ZE. Acute toxicity study of liposomal antioxidant formulations containing N-acetylcysteine, alpha-tocopherol, and gamma-tocopherol in rats. J Liposome Res 2012;22:158-67.
32. Saari M, Vidgren MT, Koskinen MO, et al. Pulmonary distribution and clearance of two beclomethasone liposome formulations in healthy volunteers. Int J Pharm 1999;181:1-9.
33. Storm G, Wilms HP, Crommelin DJ. Liposomes and biotherapeutics. Biotherapy 1991;3:25-42.
34. Suntres ZE, Shek PN. Treatment of LPS-induced tissue injury: role of liposomal antioxidants. Shock 1996;6:S57-64.
35. Suntres ZE, Hepworth SR, Shek PN. Protective effect of liposomeassociated alpha-tocopherol against paraquat-induced acute lung toxicity. Biochem Pharmacol 1992;44:1811-18.
36. Lyle P, Mitsopoulos P, Suntres ZE. N-acetylcysteine modulates the cytotoxic effects of paclitaxel. Chemotherapy 2011;57:298-304.
37. Glantzounis GK, Yang W, Koti RS, et al. The role of thiols in liver ischemia-reperfusion injury. Curr Pharm Des 2006;12:2891-901.
38. Patsoukis N, Georgiou CD. Determination of the thiol redox state of organisms: new oxidative stress indicators. Anal Bioanal Chem 2004;378:1783-92.
39. Uchida K. Future of toxicology-lipid peroxidation in the future: from biomarker to etiology. Chem Res Toxicol 2007;20:3-5.
40. Eiserich JP, Hristova M, Cross CE, et al. Formation of nitric oxidederived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998;391:393-7.
41. Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys 1998;356:1-11.
42. Ozer J, Ratner M, Shaw M, et al. The current state of serum biomarkers of hepatotoxicity. Toxicology 2008;245:194-205.
43. Cigremis Y, Turel H, Adiguzel K, et al. The effects of acute acetaminophen toxicity on hepatic mRNA expression of SOD, CAT, GSH-Px, levels of peroxynitrite, nitric oxide, reduced glutathione, and malondialdehyde in rabbit. Mol Cell Biochem 2009;323:31-8.
44. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA. N-Acetylcysteine - a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007;7:355-9.
45. Sadowska AM, Manuel-y-Keenoy B, De Backer WA. Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review. Pulm Pharmacol Ther 2007;20:9-22.
46. Lin JH, Levy G. Sulfate depletion after acetaminophen administration and replenishment by infusion of sodium sulfate or N-acetylcysteine in rats. Biochem Pharmacol 1981;30:2723-5.
47. Kheradpezhouh E, Panjehshahin M-R, Miri R, et al. Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine. Eur J Pharmacol 2010;628:274-81.
48. Terneus MV, Brown JM, Carpenter AB, Valentovic MA. Comparison of S-adenosyl-L-methionine (SAMe) and N-acetylcysteine (NAC) protective effects on hepatic damage when administered after acetaminophen overdose. Toxicology 2008;244:25-34.
49. Fishbane S, Durham JH, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004;15:251-60.
50. Gillissen A, Nowak D. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy. Respir Med 1998;92: 609-23.
51. Mandal AK, Das S, Basu MK, et al. Hepatoprotective activity of liposomal flavonoid against arsenite-induced liver fibrosis. J Pharmacol Exp Ther 2007;320:994-1001.
52. Wu J, Nantz MH, Zern MA. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci 2002;7:d717-25.
53. Wu J, Liu L, Yen RD, et al. Liposome-mediated extracellular superoxide dismutase gene delivery protects against acute liver injury in mice. Hepatology 2004;40:195-204.
54. Albano E, Rundgren M, Harvison PJ, et al. Mechanisms of N-acetyl-p-benzoquinone imine cytotoxicity. Mol Pharmacol 1985;28:306-11.
55. Dai Y, Cederbaum AI. Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. J Pharmacol Exp Ther 1995;273:1497-505.
56. James LP, Mayeux PR, Hinson JA. Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 2003;31:1499-506.
57. James LP, McCullough SS, Knight TR, et al. Acetaminophen toxicity in mice lacking NADPH oxidase activity: role of peroxynitrite formation and mitochondrial oxidant stress. Free Radic Res 2003;37:1289-97.
58. Tarantino G, Di Minno MN, Capone D. Drug-induced liver injury: is it somehow foreseeable World J Gastroenterol 2009;15: 2817-33.
59. Adams DH, Ju C, Ramaiah SK, et al. Mechanisms of immunemediated liver injury. Toxicol Sci 2010;115:307-21.
60. Lawson JA, Farhood A, Hopper RD, et al. The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 2000;54:509-16.
61. Toklu HZ, Sehirli AO, Velioglu-O gunçA, et al. Acetaminopheninduced toxicity is prevented by [beta]-d-glucan treatment in mice. Eur J Pharmacol 2006;543:133-40.
62. Ramachandran A, Lebofsky M, Weinman SA, Jaeschke H. The impact of partial manganese superoxide dismutase (SOD2)- deficiency on mitochondrial oxidant stress, DNA fragmentation and liver injury during acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 2011;251:226-33.
63. Gaut JP, Yeh GC, Tran HD, et al. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proc Natl Acad Sci USA 2001;98:11961-6.
64. Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm 2008;2008:135625-8.
65. Winterbourn CC. Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid. Toxicology 2002;181: 223-7.
66. Mitsopoulos P, Suntres ZE. Cytotoxicity and gene array analysis of alveolar epithelial A549 cells exposed to paraquat. Chem Biol Interact 2010;188:427-36.
67. Allen TM, Martin FJ. Advantages of liposomal delivery systems for anthracyclines. Semin Oncol 2004;31:5-15.
68. Gabizon A, Martin F. Polyethylene glycol-coated (pegylated) liposomal doxorubicin. Rationale for use in solid tumours. Drugs 1997;54:15-21.
69. Samad A, Sultana Y, Aqil M. Liposomal drug delivery systems: an update review. Curr Drug Deliv 2007;4:297-305.